{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:51:53Z","timestamp":1779126713335,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adverse drug reactions (ADRs) are an important concern in the medication process and can pose a substantial economic burden for patients and hospitals. Because of the limitations of clinical trials, it is difficult to identify all possible ADRs of a drug before it is marketed. We developed a new model based on data mining technology to predict potential ADRs based on available drug data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Based on the Word2Vec model in Nature Language Processing, we propose a new knowledge graph embedding method that embeds drugs and ADRs into their respective vectors and builds a logistic regression classification model to predict whether a given drug will have ADRs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>First, a new knowledge graph embedding method was proposed, and comparison with similar studies showed that our model not only had high prediction accuracy but also was simpler in model structure. In our experiments, the AUC of the classification model reached a maximum of 0.87, and the mean AUC was 0.863.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this paper, we introduce a new method to embed knowledge graph to vectorize drugs and ADRs, then use a logistic regression classification model to predict whether there is a causal relationship between them. The experiment showed that the use of knowledge graph embedding can effectively encode drugs and ADRs. And the proposed ADRs prediction system is also very effective.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-021-01402-3","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T13:06:30Z","timestamp":1612443990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Prediction of adverse drug reactions based on knowledge graph embedding"],"prefix":"10.1186","volume":"21","author":[{"given":"Fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"9237","key":"1402_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/s0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management.  Lancet. 2000;356(9237):1255\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(00)02799-9.","journal-title":"The Lancet"},{"key":"1402_CR2","doi-asserted-by":"crossref","unstructured":"Allison, Biotechnology MJN. Reinventing clinical trials 2012;30(6):562\u2013562","DOI":"10.1038\/nbt0612-562a"},{"key":"1402_CR3","doi-asserted-by":"crossref","unstructured":"Bouvy JC, De\u00a0Bruin ML, Koopmanschap MAJDS. Epidemiology of adverse drug reactions in europe: a review of recent observational studies 2015;38(5):437\u2013453","DOI":"10.1007\/s40264-015-0281-0"},{"issue":"7139","key":"1402_CR4","first-page":"975","volume":"446","author":"KM Giacomini","year":"2007","unstructured":"Giacomini KM, Krauss RM, Roden DM, Eichelbaum M, Hayden MR, Nakamura YJN. When good drugs go bad. 2007;446(7139):975\u20137.","journal-title":"When good drugs go bad"},{"issue":"7403","key":"1402_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature11159","volume":"486","author":"E Lounkine","year":"2012","unstructured":"Lounkine E, Keiser MJ, Whitebread S, Mikhailov D, Hamon J, Jenkins JL, Lavan P, Weber E, Doak AK, C\u00f4t\u00e9 S, Shoichet BK, Urban L. Large-scale prediction and testing of drug activity on side-effect targets. Nature. 2012;486(7403):361\u20137. https:\/\/doi.org\/10.1038\/nature11159.","journal-title":"Nature"},{"key":"1402_CR6","doi-asserted-by":"crossref","unstructured":"Watanabe JH, McInnis T, Hirsch JDJAoP. Cost of prescription drug-related morbidity and mortality, 2018;106002801876515","DOI":"10.1177\/1060028018765159"},{"issue":"21","key":"1402_CR7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/s1359-6446(05)03632-9","volume":"10","author":"S Whitebread","year":"2005","unstructured":"Whitebread S, Hamon J, Bojanic D, Urban L. Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discov Today. 2005;10(21):1421\u201333. https:\/\/doi.org\/10.1016\/s1359-6446(05)03632-9.","journal-title":"Drug Discovery Today"},{"issue":"1","key":"1402_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/bib\/bbv020","volume":"17","author":"J Li","year":"2015","unstructured":"Li J, Zheng S, Chen B, Butte AJ, Swamidass SJ, Lu Z. A survey of current trends in computational drug repositioning. Briefings Bioinform. 2015;17(1):2\u201312. https:\/\/doi.org\/10.1093\/bib\/bbv020.","journal-title":"Briefings in Bioinformatics"},{"issue":"9","key":"1402_CR9","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1021\/acs.jcim.5b00120","volume":"55","author":"VI P\u00e9rez-Nueno","year":"2015","unstructured":"P\u00e9rez-Nueno VI, Souchet M, Karaboga AS, Ritchie DW. Gesse: Predicting drug side effects from drug-target relationships. J Chem Inform Model. 2015;55(9):1804\u201323. https:\/\/doi.org\/10.1021\/acs.jcim.5b00120.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"S21","key":"1402_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12859-018-2544-0","volume":"19","author":"S Dey","year":"2018","unstructured":"Dey S, Luo H, Fokoue A, Hu J, Zhang P. Predicting adverse drug reactions through interpretable deep learning framework. BMC Bioinformatics. 2018;19(S21):476. https:\/\/doi.org\/10.1186\/s12859-018-2544-0.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"1402_CR11","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.3390\/molecules23123193","volume":"23","author":"B Hu","year":"2018","unstructured":"Hu B, Wang H, Wang L, Yuan W. Adverse drug reaction predictions using stacking deep heterogeneous information network embedding approach. Molecules. 2018;23(12):3193. https:\/\/doi.org\/10.3390\/molecules23123193.","journal-title":"Molecules"},{"issue":"5","key":"1402_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2174\/1386207321666180524110013","volume":"21","author":"H Luo","year":"2018","unstructured":"Luo H, Fokoue-Nkoutche A, Singh N, Yang L, Hu J, Zhang P. Molecular docking for prediction and interpretation of adverse drug reactions. Comb Chem High Throughput Screen. 2018;21(5):314\u201322. https:\/\/doi.org\/10.2174\/1386207321666180524110013.","journal-title":"Combinatorial Chemistry & High Throughput Screening"},{"issue":"1","key":"1402_CR13","doi-asserted-by":"publisher","first-page":"16416","DOI":"10.1038\/s41598-017-16674-x","volume":"7","author":"DM Bean","year":"2017","unstructured":"Bean DM, Wu H, Iqbal E, Dzahini O, Ibrahim ZM, Broadbent M, Stewart R, Dobson RJB. Knowledge graph prediction of unknown adverse drug reactions and validation in electronic health records. Sci Reports. 2017;7(1):16416. https:\/\/doi.org\/10.1038\/s41598-017-16674-x.","journal-title":"Scientific Reports"},{"issue":"1","key":"1402_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/bib\/bbx099","volume":"20","author":"E Mu\u00f1oz","year":"2017","unstructured":"Mu\u00f1oz E, Nov\u00e1\u010dek V, Vandenbussche P-Y. Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models. Briefings Bioinform. 2017;20(1):190\u2013202. https:\/\/doi.org\/10.1093\/bib\/bbx099.","journal-title":"Briefings in Bioinformatics"},{"key":"1402_CR15","doi-asserted-by":"publisher","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 2017;46(D1):1074\u20131082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","DOI":"10.1093\/nar\/gkx1037"},{"issue":"D1","key":"1402_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2015","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2015;44(D1):1075\u20139. https:\/\/doi.org\/10.1093\/nar\/gkv1075.","journal-title":"Nucleic Acids Research"},{"key":"1402_CR17","unstructured":"Mikolov T, Chen K, Corrado G, Dean J. Efficient estimation of word representations in vector space. arXiv:1301.3781 2013"},{"issue":"17","key":"1402_CR18","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.2169\/internalmedicine.2740-19","volume":"58","author":"T Kawaguchi","year":"2019","unstructured":"Kawaguchi T, Arinaga-Hino T, Shimizu M, Tanikawa K, Tokushige T, Hirai S, Nagamatsu H, Tateishi H, Takata A, Ide T, Torimura T. Immune-mediated drug-induced liver injury caused by laninamivir octanoate hydrate. Internal Med. 2019;58(17):2501\u20135. https:\/\/doi.org\/10.2169\/internalmedicine.2740-19.","journal-title":"Internal Medicine"},{"issue":"4","key":"1402_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.amjms.2018.11.017","volume":"357","author":"JM Kwan","year":"2019","unstructured":"Kwan JM, Cheng R, Feldman LE. Hepatotoxicity and recurrent NSTEMI while on pembrolizumab for metastatic giant cell bone tumor. Am. J. Med. Sci. 2019;357(4):343\u20137. https:\/\/doi.org\/10.1016\/j.amjms.2018.11.017.","journal-title":"The American Journal of the Medical Sciences"},{"issue":"10","key":"1402_CR20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/s0399-8320(06)73517-5","volume":"30","author":"L Fremond","year":"2006","unstructured":"Fremond L, Diebold MD, Thiefin G. Acute pseudoangiocholitic hepatitis probably induced by tamsulosin. Gastroenterol Clin Biol. 2006;30(10):1224\u20135. https:\/\/doi.org\/10.1016\/s0399-8320(06)73517-5.","journal-title":"Gastroenterol Clin Biol"},{"key":"1402_CR21","unstructured":"Zheng F. Study on the mechanism of panax notoginseng resisting liver fibrosis induced by naltrexone. PhD thesis, KUNMINGUNIVERSITY OF SCIENCEAND TECHNOLOGY (2015). https:\/\/kns-cnki-net-443.webvpn.cams.cn\/KCMS\/detail\/detail.aspx?dbname=CMFD201601&filename=1015641561.nh"},{"issue":"4","key":"1402_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","volume":"21","author":"M Chen","year":"2016","unstructured":"Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W. Dilirank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Disco Today. 2016;21(4):648\u201353. https:\/\/doi.org\/10.1016\/j.drudis.2016.02.015.","journal-title":"Drug Discovery Today"},{"issue":"7","key":"1402_CR23","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.drudis.2019.03.003","volume":"24","author":"CY Lee","year":"2019","unstructured":"Lee CY, Chen Y-PP. Machine learning on adverse drug reactions for pharmacovigilance. Drug Discov Today. 2019;24(7):1332\u201343. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.003.","journal-title":"Drug Discovery Today"},{"issue":"9","key":"1402_CR24","doi-asserted-by":"publisher","first-page":"106298","DOI":"10.1371\/journal.pone.0106298","volume":"9","author":"MX LaBute","year":"2014","unstructured":"LaBute MX, Zhang X, Lenderman J, Bennion BJ, Wong SE, Lightstone FC. Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machines. PLoS ONE. 2014;9(9):106298. https:\/\/doi.org\/10.1371\/journal.pone.0106298.","journal-title":"PLoS ONE"},{"key":"1402_CR25","doi-asserted-by":"publisher","unstructured":"Cao D-S, Xiao N, Li Y-J, Zeng W-B, Liang Y-Z, Lu A-P, Xu Q-S, Chen A. Integrating multiple evidence sources to predict adverse drug reactions based on a systems pharmacology model. CPT Pharm Syst Pharmacol. 2015;4(9):498\u2013506. https:\/\/doi.org\/10.1002\/psp4.12002","DOI":"10.1002\/psp4.12002"},{"issue":"1","key":"1402_CR26","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41598-017-00908-z","volume":"7","author":"S Jamal","year":"2017","unstructured":"Jamal S, Goyal S, Shanker A, Grover A. Predicting neurological adverse drug reactions based on biological, chemical and phenotypic properties of drugs using machine learning models. Sci Reports. 2017;7(1):872. https:\/\/doi.org\/10.1038\/s41598-017-00908-z.","journal-title":"Scientific Reports"},{"issue":"18","key":"1402_CR27","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2169\/internalmedicine.2708-19","volume":"58","author":"N Kuniyoshi","year":"2019","unstructured":"Kuniyoshi N, Miyakawa H, Matsumoto K, Tsunashima H, Sekine K, Tsujikawa T, Mabuchi M, Doi S, Kikuchi K. Detection of anti-mitochondrial antibodies accompanied by drug-induced hepatic injury due to atorvastatin. Internal Med. 2019;58(18):2663\u20137. https:\/\/doi.org\/10.2169\/internalmedicine.2708-19.","journal-title":"Internal Medicine"},{"issue":"4","key":"1402_CR28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/mjt.0000000000000829","volume":"26","author":"TT Brehm","year":"2019","unstructured":"Brehm TT, Wehmeyer MH, Fuhrmann V, Sch\u00e4fer H, Kluwe J. Severe acute liver injury following therapeutic doses of acetaminophen in a patient with spinal muscular atrophy. Am J Therap. 2019;26(4):528\u20139. https:\/\/doi.org\/10.1097\/mjt.0000000000000829.","journal-title":"American Journal of Therapeutics"},{"issue":"6","key":"1402_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4166\/kjg.2019.73.6.360","volume":"73","author":"SY Moon","year":"2019","unstructured":"Moon SY, Baek YH, Lee SW. Drug induced liver injury by prophylactic administration of albendazole. Korean J Gastroenterol. 2019;73(6):360. https:\/\/doi.org\/10.4166\/kjg.2019.73.6.360.","journal-title":"The Korean Journal of Gastroenterology"},{"key":"1402_CR30","doi-asserted-by":"publisher","unstructured":"Kopeck\u00fd J, Kube\u010dek O, Geryk T, Podhola M, \u017diaran M, Priester P, Hani\u0161ov\u00e1 M, Bo\u0159ilov\u00e1 S. Hepatic injury induced by a single dose of nivolumab: a case report and literature review. Klinicka Onkol 2019;32(2):133\u2013138. https:\/\/doi.org\/10.14735\/amko2019133","DOI":"10.14735\/amko2019133"},{"issue":"3","key":"1402_CR31","doi-asserted-by":"publisher","first-page":"226340","DOI":"10.1136\/bcr-2018-226340","volume":"12","author":"K Gisi","year":"2019","unstructured":"Gisi K, Ispiroglu M, Kantarceken B, Sayar H. Severe cholestasis due to azathioprine in behcet\u2019s disease. BMJ Case Reports. 2019;12(3):226340. https:\/\/doi.org\/10.1136\/bcr-2018-226340.","journal-title":"BMJ Case Reports"},{"issue":"47","key":"1402_CR32","doi-asserted-by":"publisher","first-page":"18098","DOI":"10.1097\/md.0000000000018098","volume":"98","author":"A Carretero-Gonzalez","year":"2019","unstructured":"Carretero-Gonzalez A, Salamanca Santamaria J, Castellano D, de Velasco G. Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinoma. Medicine (Baltimore). 2019;98(47):18098. https:\/\/doi.org\/10.1097\/md.0000000000018098.","journal-title":"Medicine (Baltimore)"},{"issue":"18","key":"1402_CR33","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.2169\/internalmedicine.2554-18","volume":"58","author":"T Ota","year":"2019","unstructured":"Ota T, Masuda N, Matsui K, Yamada T, Tanaka N, Fujimoto S, Fukuoka M. Successful desensitization with crizotinib after crizotinib-induced liver injury in ROS1-rearranged lung adenocarcinoma. Internal Med. 2019;58(18):2651\u20135. https:\/\/doi.org\/10.2169\/internalmedicine.2554-18.","journal-title":"Internal Medicine"},{"issue":"4","key":"1402_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bja.2019.01.003","volume":"122","author":"S Rajan","year":"2019","unstructured":"Rajan S, Garg D, Cummings KC, Krishnaney AA. Hepatotoxicity after sevoflurane anaesthesia: a new twist to an old story. Br J Anaesth. 2019;122(4):63\u20134. https:\/\/doi.org\/10.1016\/j.bja.2019.01.003.","journal-title":"British Journal of Anaesthesia"},{"key":"1402_CR35","doi-asserted-by":"publisher","unstructured":"Features and outcomes of 899 patients with drug-induced liver injury: the dilin prospective study. Gastroenterology 148(7), 1340\u201313527 (2015). https:\/\/doi.org\/10.1053\/j.gastro.2015.03.006","DOI":"10.1053\/j.gastro.2015.03.006"},{"issue":"5","key":"1402_CR36","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1378\/chest.129.5.1167","volume":"129","author":"RL Levine","year":"2006","unstructured":"Levine RL, Hursting MJ, McCollum D. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction. Chest. 2006;129(5):1167\u201375. https:\/\/doi.org\/10.1378\/chest.129.5.1167.","journal-title":"Chest"},{"issue":"4","key":"1402_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.gastrohep.2016.02.010","volume":"40","author":"G Macedo","year":"2017","unstructured":"Macedo G, Silva M, Vilas-Boas F, Lopes S, Peixoto A, Carneiro F. Tibolone-induced acute hepatitis: Well-known drug, little-known complication. Gastroenterol Hepatol. 2017;40(4):298\u2013300. https:\/\/doi.org\/10.1016\/j.gastrohep.2016.02.010.","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"key":"1402_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/902892","volume":"2013","author":"RR Vanga","year":"2013","unstructured":"Vanga RR, Bal B, Olden KW. Adderall induced acute liver injury: a rare case and review of the literature. Case Rep Gastrointestinal Med. 2013;2013:1\u20133. https:\/\/doi.org\/10.1155\/2013\/902892.","journal-title":"Case Reports in Gastrointestinal Medicine"},{"issue":"2","key":"1402_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/toxsci\/kfy244","volume":"167","author":"G Giustarini","year":"2019","unstructured":"Giustarini G, Vrisekoop N, Kruijssen L, Wagenaar L, van Staveren S, van Roest M, Bleumink R, Bol-Schoenmakers M, Weaver RJ, Koenderman L, Smit J, Pieters R. Trovafloxacin-induced liver injury: Lack in regulation of inflammation by inhibition of nucleotide release and neutrophil movement. Toxicol Sci. 2019;167(2):385\u201396. https:\/\/doi.org\/10.1093\/toxsci\/kfy244.","journal-title":"Toxicological Sciences"},{"key":"1402_CR40","doi-asserted-by":"publisher","unstructured":"Bolado\u00a0Concejo F, Capdevila\u00a0Bastons F, Zozaya\u00a0Urmeneta JM, Gonzalez de\u00a0la Higuera B, Garcia\u00a0Sanchotena JL. Hepatotoxicity caused by iopromide. Rev Esp Enferm Dig 2008;100(6):377\u20138. https:\/\/doi.org\/10.4321\/s1130-01082008000600017","DOI":"10.4321\/s1130-01082008000600017"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-021-01402-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T13:25:16Z","timestamp":1612445116000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-021-01402-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1186\/s12911-021-01402-3","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}